Abstract

BackgroundGradually increasing the interval between doses (or reducing the doses) of anti-TNF drugs does not appear to increase the risk of relapse or progression among patients with established rheumatoid arthritis...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call